Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes

BMJ (Online)

Volumn 344, Issue 7842, 2012, Pages

  Yudkin, John S ^a   Lipska, Kasia J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATARACT EXTRACTION; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; GLYCEMIC CONTROL; HUMAN; KIDNEY FAILURE; LASER COAGULATION; LETTER; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK REDUCTION; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; GLUCOSE BLOOD LEVEL; MORTALITY; NOTE;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS;

EID: 84858330200     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e708     Document Type: Letter

References (5)

1. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 2011;343:d6898. (24 November.)
2. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS). VIII Study design, progress and performance. Diabetologia 1991;34:877-90.
3. Yudkin JS, Lipska KJ, Montori VM. The idolatry of the surrogate. BMJ 2011;343:d7995. (28 December.)
4. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2011;2:CD008143.
5. Yudkin JS, Richter B, Gale EAM. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia 2010;53:2079-85.